Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis

Table 4 Performance of optimal platelet cut-offs in validation cohort

	Platelet cut-off (× 109/L)	AUROC	Sensitivity (%)	Specificity (%)	Positive predictive value (%)	Negative predictive value (%)
Entire validation cohort	143	0.85 (0.76-0.93)	79	84	33	98
HBV	143	0.81 (0.53-1.00)	83	82	29	98
HCV	143	0.83 (0.72-0.94)	75	86	31	98
HDV	143	0.87 (0.74-1.00)	100	60	47	100

Table 4 displays the calculated cut-offs and sensitivity, specificity, positive predictive values, and negative predictive values for each the calculated optimal cut-off within the validation cohort. AUROC: Area Under the Receiver Operating Characteristics curve. HBV: Hepatitis B virus; HCV: Hepatitis C virus; HDV: Hepatitis D virus.